How can pharmaceutical companies get to insights-driven customer engagement, that is the subject of today's program. We meet with one of our favorite marketing leaders over in Silicon Valley, Leilani Latimer who leads Global Marketing as Sr. Di

1-1 with Janssen's Jane Griffiths (Group Chairman EMEA) on cancer research, blood cancer awareness, pricing and affordability in oncology

Oct 4th, 2016 17m 32s

In our CEO series, we meet with Janssen's Group Chairman to review blood cancer awareness month, discuss how where we are in the cure for cancer and look at how big pharma should help patients manage the disease journey. Ulrich Neumann, US Mana

Expert Panel: New Ways to Pay for Pharma Innovation?

Aug 24th, 2016 46m

While the market becomes increasingly crowded with innovator drugs, pharma is finding it harder to recoup development costs. Join our panel of experts to understand how we should build innovative, cost-effective payment models based on 21st-ce

Patient engagement strategies in the digital environment

Jul 13th, 2016 24m 45s

It's become widely understood that a focus on patient value has become mission critical as we witness the force of consumerization in healthcare. Join us for a wide ranging conversation on the new digital ecosystem and the type of engagement m

Debating Price vs Value in Oncology

Apr 25th, 2016 52m 56s

Join us for this critical discussion about exploding cost in cancer care. Ahead of ASCO, we'll address some of the value frameworks and metrics, and what pharma ought to do to provide better evidence for their prices. You'll get to hear a prett

CEO Interview with Paul Perrault

Apr 5th, 2016 22m 55s

CSL Behring's CEO in a wide-ranging conversation about value, patient focus, skyrocketing healthcare cost and the constant need to innovate.

Patient-Friendly Clinical Research

Jun 22nd, 2015 16m 15s

In this conversation with pharma change maker Paulo Moreira, we'll discuss how clinical trials and drug development can become more patient friendly. Paulo is EMD Serono's Vice President and Head of Global Clinical Operations for External Innov

4 Trends in Oncology Commercialization

May 29th, 2015 12m 45s

In this conversation with renowned industry expert Maria Whitman of ZS Associates we'll discuss the overarching trends in Oncology that are most important to consider in terms of value and market access, explore the role of pathways and new mod

Rate